Presenilin-2 (PSEN2) mutation Thr421Met was identified from a 57-years old patient with early onset Alzheimer's disease (EOAD) for the first time in Korea. This evidence concerns the gene PSEN2 and early-onset autosomal dominant Alzheimer disease.